Lexicon Pharmaceuticals
LXRX
#6807
Rank
โ‚น57.72 B
Marketcap
โ‚น138.14
Share price
3.40%
Change (1 day)
128.07%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.27. In 2024 the company made an earnings per share (EPS) of -โ‚น58.17 an increase over its 2023 EPS that were of -โ‚น72.71.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.8%
2024-โ‚น58.17-20%
2023-โ‚น72.7131.15%
2022-โ‚น55.44-0%
2021-โ‚น55.4410.91%
2020-โ‚น49.99-145.08%
2019โ‚น110.88-206.09%
2018-โ‚น104.52-5.74%
2017-โ‚น110.88-10.95%
2016-โ‚น124.512640%
2015-โ‚น4.54-96.34%
2014-โ‚น124.02-2.53%
2013-โ‚น127.24-9.09%
2012-โ‚น139.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,615-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น406.25-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,919-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น539.85 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น217.21-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น45.44 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น68.16 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น247.20-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น6,972 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA